April 2017 Product Spotlight: Emerging Technologies, Part 2
This month’s issue features emerging technologies from such companies as Clinical Genomics, Hamilton Storage, and Symcel.
Read More
Search Results for: lung cancer
Owlstone Medical Opens High-Volume Breath Biopsy Lab
Facilities will have access to high-throughput biomarker services for identification of novel breath biomarkers in disease diagnostics and precision medicine applications.
Read More
Multiplex cfDNA Reference Standard Set in Synthetic Plasma
The new format directly addresses DNA extraction, one of the key sources of variability in cfDNA assays.
Read More
The Evolution of the PD-L1 Testing Market
The dynamic PD-L1 space is providing opportunities to undertake real-time market analysis and ultimately improve our understanding of novel biomarker adoption.
Read More
ROS1, RET Now Available in Liquid Biopsy Test
The test provides highly sensitive results in 72 hours for non-small cell lung cancer patients.
Read More